Hyprotek, Inc.

Hyprotek, Inc. is a privately held biomedical company headquartered in Spokane, Washington, in the United States. According to its official website, the company develops and produces patented medical technologies designed to improve the safety and efficiency of intravenous therapy, with a focus on assisting hospitals around the world. Its stated vision is the creation of a "virtual sterile pipeline" in which potential harm to patients from medication errors and hospital-acquired infections is substantially reduced or eliminated. The company's product portfolio centers on infection prevention and safe medication handling in hospital settings. Its flagship offering, PortProtek, is an intravascular catheter (IVC) port cap — a small plastic cap that fastens securely to the access port at the terminal end of an intravenous catheter line, creating an air-tight seal that reduces airborne pathogens. The system uses a pair of caps: the first contains a strong antimicrobial solution and remains affixed to the IVC port when not in use, while the second contains a cleaning and disinfectant solution used immediately before access. The second cap can also be used to clean, disinfect, and protect the male luer connector. Hyprotek states that PortProtek caps work as a single-use system for high-level disinfection to protect the delivery of intravascular fluids via access ports. Hyprotek also offers a Mixing and Administration Syringe, which allows the mixing and administration of medications in a completely closed and sterile system, thereby markedly reducing the risk of contamination for the patient. The syringe system is available in a variety of volumes from 2cc to 160cc and is packaged with a single dose of a specific lyophilized drug, the correct volume and type of diluent, and a penetrator to puncture the sealed drug, enabling sterile mixing of the drug into solution. Because the system is enclosed in a sterile package, it prevents particulate or microbial contamination from the environment and minimizes the drug exposure risk to the caregiver from chemotherapy toxicity or allergic reactions during mixing and administration. Beyond these core products, Hyprotek's hospital infection prevention offerings include high-level disinfectants for puncture and surgical sites, antiseptic and semi-transparent dressing areas for catheter sites, antimicrobial non-antibiotic dressings for wounds, diabetic ulcers, and post-operative incisions, and hand sanitization products for healthcare, food preparation, and other sterile use settings. The company describes itself as led by an elite team of industry veterans with expertise in medicine, finance, engineering, marketing, and research. It markets its solutions directly to hospitals and healthcare providers, positioning itself at the intersection of patient safety, infection control, and sterile medication delivery. Hyprotek's technologies have been referenced in clinical literature, including the American Journal of Infection Control, and its PortProtek technology has been associated with a product marketed by Excelsior Medical as SwabFlush. The company remains active and privately held, with no public listing.

Hyprotek, Inc. is a biomedical company based in Spokane, Washington, United States. Public information about the company's founding date and early history is limited; its official website and Wikidata entry describe it as a company in Spokane, United States, focused on developing and producing patented medical technologies to improve the safety and efficiency of intravenous therapy. The company's stated mission centers on patient safety in hospital settings. It describes its vision as the creation of a "virtual sterile pipeline" wherein potential harm to patients from medication errors and hospital-acquired infections will be substantially reduced or eliminated. This vision has guided the development of its product line, which addresses two related problems in intravenous care: contamination at catheter access ports and contamination during the mixing and administration of medications. Hyprotek's flagship technology, PortProtek, is an intravascular catheter (IVC) port cap designed to thoroughly clean and disinfect access ports at the terminal ends of intravenous catheter lines. The device consists of a small plastic cap that fastens securely to the access port, creating an air-tight seal that reduces airborne pathogens. The system uses two caps: the first contains a strong antimicrobial solution effective at killing microorganisms that might contaminate the port and remains affixed to the IVC port when not in use; the second contains a cleaning and disinfectant solution to eliminate potential contamination immediately prior to access. The second cap can also be used to clean, disinfect, and protect the male luer connector. Hyprotek states that PortProtek caps work as a single-use system for high-level disinfection to protect the delivery of intravascular fluids via access ports. The technology has been referenced in the American Journal of Infection Control, and a related product has been marketed by Excelsior Medical as SwabFlush. The company's second major product is the Hyprotek Mixing and Administration Syringe, which allows the mixing and administration of medications in a completely closed and sterile system, markedly reducing the risk of contamination for the patient. The system is available in syringe volumes from 2cc to 160cc and is packaged with a single dose of a specific lyophilized drug, the correct volume and type of diluent, and a penetrator to puncture the sealed drug, enabling sterile mixing of the drug into solution. Because the system is enclosed in a sterile package, it prevents particulate or microbial contamination from the environment. It also minimizes the drug exposure risk to the caregiver from chemotherapy toxicity or allergic reactions during mixing and administration. Hyprotek's broader hospital infection prevention portfolio includes high-level disinfectants for puncture and surgical sites, antiseptic and semi-transparent dressing areas for catheter sites, antimicrobial non-antibiotic dressings for wounds, diabetic ulcers, and post-operative incisions, and hand sanitization products for healthcare, food preparation, and other sterile use settings. The company describes itself as led by an elite team of industry veterans with expertise in medicine, finance, engineering, marketing, and research. It markets its solutions to hospitals around the world and remains a privately held, active company. No public listing, parent company, or major ownership changes have been disclosed in the available sources.

A biomedical company focused on patient safety, infection prevention, and sterile intravenous therapy for hospitals worldwide, aiming to create a "virtual sterile pipeline".

• PortProtek

  An intravascular catheter (IVC) port cap that thoroughly cleans and disinfects access ports at the terminal ends of intravenous catheter lines. A small plastic cap fastens securely to the access port, creating an air-tight seal that reduces airborne pathogens. Uses two caps: the first contains a strong antimicrobial solution and remains affixed when not in use; the second contains a cleaning/disinfectant solution used immediately before access and can also clean, disinfect, and protect the male luer connector.

• Hyprotek Mixing and Administration Syringe

  Allows the mixing and administration of medications in a completely closed and sterile system, markedly reducing the risk of contamination for the patient. Available in syringe volumes from 2cc to 160cc, packaged with a single dose of a specific lyophilized drug, the correct volume and type of diluent, and a penetrator to puncture the sealed drug, enabling sterile mixing of the drug into solution. Prevents particulate or microbial contamination from the environment and minimizes drug exposure risk to the caregiver from chemotherapy toxicity or allergic reactions.

• Hospital Infection Prevention Products

  Includes high-level disinfectants for puncture and surgical sites, antiseptic and semi-transparent dressing areas for catheter sites, antimicrobial non-antibiotic dressings for wounds, diabetic ulcers, and post-operative incisions, and hand sanitization products for healthcare, food preparation, and other sterile use settings.

1. 1Intravenous Therapy & Infusion Devices | Hyprotek Inc.hyprotekinc.com
2. 2Hospital Infection Prevention Products | Hyprotek Inc.hyprotekinc.com
3. 3Hyprotek Mixing / Administration Syringe | Hyprotek Inc.hyprotekinc.com
4. 4Hyprotek (United States) - Wikidatawikidata.org